Hidradenitis Suppurativa | COSENTYX® (secukinumab) (2024)

Do not use COSENTYX if you have had a severe allergic reaction to secukinumab or any of the other ingredients in COSENTYX. See the Medication Guide for a complete list of ingredients.

What is the most important information I should know about COSENTYX?

COSENTYX is a medicine that affects your immune system. COSENTYX may increase your risk of having serious side effects such as:

Infections

COSENTYX may lower the ability of your immune system to fight infections and may increase your risk of infections. Some people have died from these infections.

Before starting COSENTYX, tell your doctor if you:

  • are being treated for an infection

  • have an infection that does not go away or that keeps coming back

  • have TB or have been in close contact with someone with TB

  • think you have an infection or have symptoms of an infection such as: fevers, sweats, or chills; muscle aches; cough; shortness of breath; blood in your phlegm; weight loss; warm, red, or painful skin or sores on your body; diarrhea or stomach pain; burning when you urinate or urinate more often than normal

After starting COSENTYX, call your doctor right away if you have any signs of infection listed above. Do not use COSENTYX if you have any signs of infection unless you are instructed to by your doctor.

What are the possible side effects of COSENTYX?

COSENTYX may cause serious side effects, including:

Serious allergic reactions

Serious allergic reactions can occur. Get emergency medical help right away if you get any of the following symptoms: feeling faint; swelling of your face, eyelids, lips, mouth, tongue, or throat; trouble breathing or throat tightness; chest tightness; skin rash or hives (red, itchy bumps).

If you have a severe allergic reaction, do not give another injection of COSENTYX.

Inflammatory bowel disease

New cases of inflammatory bowel disease or "flare-ups" can happen with COSENTYX, and can sometimes be serious. If you have inflammatory bowel disease (ulcerative colitis or Crohn's disease), tell your doctor if you have worsening disease symptoms during treatment with COSENTYX or develop new symptoms of stomach pain or diarrhea.

Severe skin reactions that look like eczema can happen during treatment with COSENTYX from days to months after your first dose and can sometimes lead to hospitalization. Your doctor may temporarily stop treatment with COSENTYX if you develop severe skin reactions. Tell your doctor if you have any of the following signs or symptoms:redness or rash; itching; small bumps or patches; your skin is dry or feels like leather; blisters on the hands or feet that ooze or become crusty or skin peeling.

The most common side effects of COSENTYX include: cold symptoms, diarrhea, and upper respiratory tract infections.

These are not all of the possible side effects of COSENTYX. Call your doctor for medical advice about side effects.

Before using COSENTYX, tell your doctor if you:

  • have any of the conditions or symptoms listed abovefor infections.

  • have inflammatory bowel disease (Crohn's disease or ulcerative colitis).

  • are allergic to latex. The needle cap on the COSENTYX Sensoready® pen, and 150 mg/mL and75 mg/0.5 mL prefilled syringes contains latex.

  • have recently received or are scheduled to receive an immunization (vaccine). People who take COSENTYX should not receive live vaccines. Children should be brought up to date with all vaccines before starting COSENTYX.

  • have any other medical conditions and all the medicines you take, including prescription and over‑the‑counter medicines, vitamins, and herbal supplements. Keep a list of your medicines to show your healthcare provider and pharmacist when you get a new medicine.

  • are pregnant or plan to become pregnant. It is not known if COSENTYX can harm your unborn baby. You and your doctor should decide if you will use COSENTYX.

  • are breastfeeding or plan to breastfeed. It is not known if COSENTYX passes into your breast milk.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch ↗, or call 1-800-FDA-1088.

Please see full Prescribing Information, including Medication Guide.

10/23 308659

Hidradenitis Suppurativa | COSENTYX® (secukinumab) (2024)

FAQs

Is secukinumab approved for hidradenitis suppurativa? ›

Secukinumab is currently the only IL-17A inhibitor approved for the condition. The FDA has approved secukinumab (Cosentyx, Novartis) for the treatment of moderate to severe hidradenitis suppurativa (HS) and is currently the only anti-interleukin (IL)-17A inhibitor approved for the condition.

What is the success rate of COSENTYX for HS? ›

In conclusion, the results of our real life study show that treatment with secukinumab in patients with severe HS who failed adalimumab may be safe and effective, in particular showed HiSCR was achieved at week 16 by 57.1% of patients. This score continued to improve at every follow-up reaching 71.4% at week 52.

What is the new treatment for hidradenitis suppurativa in 2024? ›

Oral Drug for Hidradenitis Suppurativa Shows Promise in Small Study | AAD 2024. A phase 2 study demonstrated positive results for remibrutinib, a BTK inhibitor, as a treatment for patients with the rare skin condition, hidradenitis suppurativa, finds a study presented at the American Academy of Dermatology Association.

How long does it take for COSENTYX to work for hidradenitis suppurativa? ›

Cosentyx for hidradenitis suppurativa started working as early as week 2 and by 16 weeks in the SUNSHINE trial 44.5% of Cosentyx patients achieved HiSCR50 compared 29.4% of placebo patients.

What is the success rate of secukinumab? ›

Alonso et al. presented data on secukinumab survival in axSpA and PsA from 154 patients in northern Spain, indicating an overall similar 1-year survival rate to our study (66% vs. 59.7%) and also a 2-year survival rate (43% vs. 31.3%), despite having a higher proportion of biologic-naïve participants [23].

What is the new shot for hidradenitis suppurativa? ›

COSENTYX® (secukinumab) is the first FDA-approved medicine of its kind to treat adults with moderate to severe hidradenitis suppurativa (HS). Hidradenitis suppurativa (HS) is a chronic, or long-lasting, inflammatory skin condition.

What is the best biologic for HS? ›

To date, adalimumab (ADA) is the only biotechnology drug approved for the management of hidradenitis suppurativa (HS), an inflammatory skin condition.

What is the best medicine for hidradenitis suppurativa? ›

Several of these medicines are approved to treat moderate to severe hidradenitis suppurativa. Two are the tumor necrosis factor inhibitors adalimumab, or Humira, and infliximab, or Remicade. These medicines work by dampening part of the immune system called tumor necrosis factor.

Is Cosentyx stronger than Humira? ›

Very few studies have directly compared Cosentyx with Humira but one, called the EXCEED trial compared the two biologics in people with psoriatic arthritis. This trial showed that treatment with Cosentyx was similar to that with Humira (or that Cosentyx was not superior to Humira).

Has anyone ever been cured of HS? ›

There's no cure for HS, so you'll have to manage the condition for life. For most people, it's a cycle of flare-ups and periods when their skin is clear.

What clears up hidradenitis suppurativa? ›

How is hidradenitis suppurativa treated?
  • Antiperspirants that are gentle on delicate skin.
  • Daily antiseptic wash to cleanse affected areas.
  • Retinoids, substances that contain vitamin A and help reduce inflammation.
  • Specific types of body wash.

How do you get HS into remission? ›

Topical antibiotics work where applied and can help in mild cases. Oral antibiotics treat the entire body, making them more likely to be prescribed in moderate or severe cases. Antibiotics combined with the antiandrogen finasteride have been shown to facilitate remission.

How do I know if COSENTYX is working? ›

Among those moderate to severe plaque psoriasis patients who kept a symptom diary (39% of people), people taking COSENTYX reported an improvement in symptoms like pain, itching, and scaling at 12 weeks, compared with those not taking COSENTYX (placebo) in the studies.

How quickly does secukinumab work? ›

Secukinumab works by blocking the effects of this protein, to reduce inflammation and the problems it can cause, such as joint pain and stiffness. It's a long-term treatment. Depending on your condition, it may take between three weeks and a year of taking secukinumab before you start to see the benefits.

How long do you stay on COSENTYX? ›

For people with moderate to severe plaque psoriasis, COSENTYX is taken once a week for 5 weeks, then once every 4 weeks thereafter.

What biologics are approved for hidradenitis suppurativa? ›

To date, adalimumab (ADA) is the only biotechnology drug approved for the management of hidradenitis suppurativa (HS), an inflammatory skin condition.

What is the new approval for hidradenitis suppurativa? ›

Basel, October 31, 2023 — Novartis, a global leader in immuno-dermatology and rheumatology, announced today that the US Food and Drug Administration (FDA) has approved Cosentyx® (secukinumab) to treat moderate to severe hidradenitis suppurativa (HS) in adults.

What is the drug of choice for hidradenitis suppurativa? ›

Adalimumab is recommended as a first-line treatment option in patients with moderate-to-severe hidradenitis suppurativa who are unresponsive to or intolerant of oral antibiotics.

What is secukinumab approved for? ›

The FDA approval of secukinumab, the first IL-17A antagonist for patients with moderate-to-severe plaque psoriasis, marks the availability of a new therapeutic option for this patient population.

Top Articles
Latest Posts
Article information

Author: Arline Emard IV

Last Updated:

Views: 5790

Rating: 4.1 / 5 (72 voted)

Reviews: 95% of readers found this page helpful

Author information

Name: Arline Emard IV

Birthday: 1996-07-10

Address: 8912 Hintz Shore, West Louie, AZ 69363-0747

Phone: +13454700762376

Job: Administration Technician

Hobby: Paintball, Horseback riding, Cycling, Running, Macrame, Playing musical instruments, Soapmaking

Introduction: My name is Arline Emard IV, I am a cheerful, gorgeous, colorful, joyous, excited, super, inquisitive person who loves writing and wants to share my knowledge and understanding with you.